欢迎来到天天文库
浏览记录
ID:54590625
大小:245.68 KB
页数:3页
时间:2020-05-02
《低分子肝素钙联合灯盏花素治疗老年肺心病疗效分析.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、重庆医学2014年7月第43卷第2O期2587论著·临床研究doi:10.3969/j.issn.1671—8348.2014.20.016低分子肝素钙联合灯盏花素治疗老年肺心病疗效分析李章白,钟伟,廖雪梅△(重庆市荣昌县人民医院内科402460)摘要:目的探讨低分子肝素钙和灯盏花素联用治疗老年肺心病的疗效。方法将2011年5月至2013年6月在该院住院的303倒确诊老年肺心病患者分为3组,A组(一lO0)、B组(n一102)、C组(一101)。A组予以常规治疗,B组在常规治疗基础上加用低分子肝素钙,c组在常规治
2、疗基础上给予低分子肝素钙和灯盏花素治疗。观察3组患者治疗后临床症状改善、血气分析和血流动力学的改变。结果3组患者临床疗效总有效率分别为59.0、73.5和90.0;B、C组患者血气分析和血流动力学治疗后较A组均有改善(P<0.05),C组优于B组(P3、号:1671—8348(2014)202587—02ClinicaIobservationofcombinedtreatmentoflowmolecularweightheparincalciumandbreviscapineinelderpulmonaryheartdiseaseLiZhangbai,ZhongWei,LiaoXuemei(DepartmentofInternalMedicine,PeoplesHospitalofRongchangCounty,Chongqing402460,China)Abs4、tract:objectiveToexploretheclinicaltherapeuticeffectofcombinedtreatmentoflowmolecularweightheparincalciumandbreviscapineinelderpulmonaryheartdisease.Methods303patientsinelderpulmonaryheartdiseaseinthehospitalfromMay2011toJune2013weredividedintothreegroups.1005、patientsingroupAwerereceivedtheroutinetherepy,102patientsofgroupBwerereceivedroutinetherapycombinedwithlowmolecularweightheparincalciumonly,101patientsofgroupCwerereceivedroutinetherapycombinedwithlowmolecularweightheparincalciumandbreviscapine.thechangesofcl6、inicalsymptom,bloodgasa—nalysis,hemorheologyingroupsbeforeandaftertreatmentwereobserved.ResultsTheeffectiveratesofgroupA,B,Cwere59.0,73.5and90.0,theresultsshowedthatthebloodgasanalysisandhemorheologyparameteringroupsBandChadmoreimprovedthangroupA(P<0.05),andb7、etteringroupCthangroupB(P8、ogyparameter,andhaslessadversereaction.Kwords:lowmolecularweightheparincalcium~breviscapine~elderpulmonaryheartdisease随着我国人口老龄化日益加剧,老年人群的呼吸系统疾病年龄6o~9o岁,平均(69.0土6.35)岁;病程15~45d,平均呈逐年递增趋势,同
3、号:1671—8348(2014)202587—02ClinicaIobservationofcombinedtreatmentoflowmolecularweightheparincalciumandbreviscapineinelderpulmonaryheartdiseaseLiZhangbai,ZhongWei,LiaoXuemei(DepartmentofInternalMedicine,PeoplesHospitalofRongchangCounty,Chongqing402460,China)Abs
4、tract:objectiveToexploretheclinicaltherapeuticeffectofcombinedtreatmentoflowmolecularweightheparincalciumandbreviscapineinelderpulmonaryheartdisease.Methods303patientsinelderpulmonaryheartdiseaseinthehospitalfromMay2011toJune2013weredividedintothreegroups.100
5、patientsingroupAwerereceivedtheroutinetherepy,102patientsofgroupBwerereceivedroutinetherapycombinedwithlowmolecularweightheparincalciumonly,101patientsofgroupCwerereceivedroutinetherapycombinedwithlowmolecularweightheparincalciumandbreviscapine.thechangesofcl
6、inicalsymptom,bloodgasa—nalysis,hemorheologyingroupsbeforeandaftertreatmentwereobserved.ResultsTheeffectiveratesofgroupA,B,Cwere59.0,73.5and90.0,theresultsshowedthatthebloodgasanalysisandhemorheologyparameteringroupsBandChadmoreimprovedthangroupA(P<0.05),andb
7、etteringroupCthangroupB(P8、ogyparameter,andhaslessadversereaction.Kwords:lowmolecularweightheparincalcium~breviscapine~elderpulmonaryheartdisease随着我国人口老龄化日益加剧,老年人群的呼吸系统疾病年龄6o~9o岁,平均(69.0土6.35)岁;病程15~45d,平均呈逐年递增趋势,同
8、ogyparameter,andhaslessadversereaction.Kwords:lowmolecularweightheparincalcium~breviscapine~elderpulmonaryheartdisease随着我国人口老龄化日益加剧,老年人群的呼吸系统疾病年龄6o~9o岁,平均(69.0土6.35)岁;病程15~45d,平均呈逐年递增趋势,同
此文档下载收益归作者所有